Australia markets close in 51 minutes

AusCann Group Holdings Ltd (AC8.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.1450+0.0050 (+3.57%)
As of 2:36PM AEDT. Market open.

AusCann Group Holdings Ltd

35 Havelock Street
Level 5
West Perth, WA 6005
Australia
61 8 6305 0705
http://auscann.com.au

Sector(s)Healthcare
IndustryDrug Manufacturers—Specialty & Generic
Full-time employees

Key executives

NameTitlePayExercisedYear born
Mr. Nicholas WoolfChief Exec. OfficerN/AN/A1968
Mr. Quentin Heath Megson A.C.A., B.Com.CFO & Joint Company Sec.N/AN/A1971
Ms. Sheena EmslieChief Operating OfficerN/AN/AN/A
Dr. Marc RussoChief Medical AdvisorN/AN/AN/A
Ms. Susan Patricia Hunter A.C.A., B.Com., BCom, F Fin, ACA, AGIA, FFin, GAICJoint Company Sec.N/AN/A1975
Amounts are as of , and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in AUD.

Description

AusCann Group Holdings Ltd, a pharmaceutical company, researches, develops, cultivates, produces, and distributes cannabinoid-based pharmaceuticals in Australia and internationally. It offers hard-shell capsules using Neuvis technology for the treatment of chronic neuropathic pain. The company is based in West Perth, Australia.

Corporate governance

AusCann Group Holdings Ltd’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.